Is high-dose glucocorticoid beneficial in COVID-19?

Valliappan Muthu, Inderpaul Singh Sehgal, Kuruswamy Thurai Prasad, Ritesh Agarwal

Source: Eur Respir J, 57 (4) 2100065; 10.1183/13993003.00065-2021
Journal Issue: April
Disease area: Airway diseases, Respiratory critical care

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Valliappan Muthu, Inderpaul Singh Sehgal, Kuruswamy Thurai Prasad, Ritesh Agarwal. Is high-dose glucocorticoid beneficial in COVID-19?. Eur Respir J, 57 (4) 2100065; 10.1183/13993003.00065-2021

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.

Related content which might interest you:
Reply: Is high-dose glucocorticoid beneficial in COVID-19?
Source: Eur Respir J, 57 (4) 2100324; 10.1183/13993003.00324-2021
Year: 2021

The efficacy of steroid with pentoxifylline in steroid resistant sarcoidosis
Source: Eur Respir J 2006; 28: Suppl. 50, 542s
Year: 2006

Cardioprotective effects of inhaled corticosteroid-containing combination therapy in COPD
Source: Eur Respir J, 53 (2) 1802420; 10.1183/13993003.02420-2018
Year: 2019

Long-term oral corticosteroid-sparing effects of anti-IL5/anti-IL5 receptor treatment.
Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies
Year: 2021

Does selenium long-term therapy restore hypothalamic-pituitary-adrenal axis in oral steroids dependant patients?
Source: Annual Congress 2009 - Asthma and comorbid conditions
Year: 2009

Investigating the steroids and long-acting β2-agonists combination: why do we need more?
Source: Eur Respir J 2004; 23: 501-502
Year: 2004

Pharmacological treatment of severe, therapy-resistant asthma in children: what can we learn from where?
Source: Eur Respir J 2011; 38: 947-958
Year: 2011

Does azithromycin-prednisolone combination therapy have additive effects than single therapy in patients with persistent asthma?
Source: Annual Congress 2009 - Aspects of uncontrolled asthma
Year: 2009

Do long-acting β2-adrenoceptor agonists enhance the anti-inflammatory effect of glucocorticoids in asthma?
Source: Eur Respir J 2001; 17: 1059-1061
Year: 2001

Mechanisms of systemic side effects of inhaled steroids
Source: Eur Respir J 2004; 24: Suppl. 48, 347s
Year: 2004

Muscle regrowth in COPD patients induced by anabolic steroids is amplified by systemic glucocorticoids (GC): A potentiating interaction between GC and IGF-1?
Source: Annual Congress 2011 - Challenges in chronic disease management: helping individuals with chronic lung disease remain stable
Year: 2011

Oral steroid-sparing effect of high-dose inhaled corticosteroids in asthma
Source: Eur Respir J, 55 (1) 1901147; 10.1183/13993003.01147-2019
Year: 2020

Differences in the glucocorticoid to progesterone receptor selectivity of inhaled glucocorticoids
Source: Eur Respir J 2006; 27: 511-516
Year: 2006

Combination of pentoxifylline and steroids in sarcoidosis treatment
Source: Eur Respir J 2005; 26: Suppl. 49, 269s
Year: 2005

Low-dose inhaled glucocorticoids are more effective tham LTRA in improving functional data in asthmatics
Source: Eur Respir J 2004; 24: Suppl. 48, 126s
Year: 2004

Impact of the combination therapy: inhaled corticosteroid and long-acting beta agonists in the prescription pattern of inhaled corticosteroids
Source: Annual Congress 2007 - Respiratory issues in primary care
Year: 2007

Anti-inflammatory effects of add-on atorvastatin therapy during the treatment of COPD patients
Source: Annual Congress 2012 - Trials in COPD: novel treatments and insights
Year: 2012

Step-up of asthma therapy: an observational study comparing increased inhaled corticosteroid dosage to combination inhaled corticosteroid/long acting beta agonist therapy in UK general practice
Source: Annual Congress 2007 - Traditional and novel approaches to assess and achieve asthma control
Year: 2007

Long-acting muscarinic antagonists: a potential add-on therapy in the treatment of asthma?
Source: Eur Respir Rev 2015; 25: 54-64
Year: 2016